Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RUMA CA&E releases Antibiotic Amnesty 2024 results
This year saw practices also drawing attention to the return of other medications.
The results were shared at this year’s BSAVA Congress.

The Responsible use of Medicines Alliance – Companion Animal and Equine (RUMA CA&E) has shared the statistics from Antibiotic Amnesty 2024, which took place last November.

During a press conference on 20 March 2025, RUMA CA&E revealed that 2,413 antibiotics, including tablets, topicals and injections, had been returned to participating practices during the campaign.

Antibiotic Amnesty 2024 marks the third year of RUMA CA&E’s One Health campaign. It aims to combat the inappropriate use or disposal of antibiotics, which can otherwise contribute to antimicrobial resistance.

RUMA CA&E says that, although 12 per cent fewer antibiotics were returned compared to 2023, it is still a significant total. Statistics showed that 2,148 tablets, 136 topicals, 47 injections and 82 liquids were returned throughout November 2024.

While the campaign is generally focused on the return of antibiotics, this year also saw practices lead discussions on the return of other medications.

Although no formal data was collected, many practices took the opportunity to extend the conversation to other unused veterinary medicines. Among the other medications returned were parasticides and hormones.

There were also reports of human drugs, including antacids and contraceptive pills, being returned during the campaign.

RUMA CA&E describes its survey as a ‘snapshot’ of the campaign, with its survey evaluation being a voluntary process for those who took part. It is considered likely that a greater number of practices did take part in the campaign, since there was a high number of practices which signed up for campaign information.

This year 333 additional practices signed up for information about the Antibiotic Amnesty campaign, bringing the total number of practices receiving campaign information to 650 practices. The volume of traffic to the campaign website also increased by 35 per cent compared to 2023.

Steve Howard, RUMA CA&E secretary general, said: “What is also pleasing to hear is that antimicrobial stewardship is becoming embedded into everyday language and behaviours in the practice environment, with a number of practices attributing the reduced level of returned antibiotics to the fact that less are being prescribed in the first place, plus the ongoing focus to educate owners about the safe use and disposal of animal medicines.

“I would like to thank the profession once again for supporting the Antibiotic Amnesty so enthusiastically.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."